FTC sues big pharmacy advantage managers above insulin rates The company brought action against Caremark, Categorical Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating methods “artificially inflated” the list price of lifestyle-conserving insulin medicines. Elevance lowers steering on ‘unprecedented’ Medicaid worries Executives stated the increased prices press... https://buschlightpeachcalories31863.blogkoo.com/about-healthcare-news-50294252